MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients

Virology

Volumn 267, Issue 2, 2000, Pages 229-236

  Stitz, Jörn ^a   Steidl, Stefanie ^a   Merget Millitzer, Heike ^a   König, Renate ^a   Müller, Peter ^a   Nocken, Frank ^a   Engelstädter, Martin ^a   Bobkova, Maria ^a   Schmitt, Isabel ^a   Kurth, Reinhard ^a   Buchholz, Christian J ^a   Cichutek, Klaus ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS VECTOR;

ANTIGEN EXPRESSION; ARTICLE; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION;

AMPHOTROPIC MURINE LEUKEMIA VIRUS; CERCOPITHECUS AETHIOPS; CHLOROCEBUS PYGERYTHRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MIRIDAE; MURINAE; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0034652687     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0121     Document Type: Article

References (44)

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 58:1986;284-291.
2. Alkhabit G., Broder C. C., Berger E. A. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J. Virol. 70:1996;5487-5494.
3. Andersen W. F. Prospects for human gene therapy. Science. 226:1984;401-409.
4. Andreassen H., Bohr H., Bohr J., Brunak S., Bugge T., Cotterill R. M., Jacobsen C., Kusk P., Lautrup B., Petersen S. B. Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods. J. Aquir. Immune Defic. Syndr. Hum. Retrovirol. 3:1990;615-622.
5. Baier M., Garber C., Müller C., Cichutek K., Kurth R. Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. Virology. 176:1990;216-221.
6. -SCID: initial trial results after 4 years. Science. 270:1995;475-480.
7. Blomberg J., Klasse P. J., Pehrson C. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus. Intervirology. 31:1990;276-284.
8. Bugelski P. J., Maleeff B. E., Klinkner A. M., Ventre J., Hart T. K. Ultrastructual evidence of an interaction between env and gag proteins during assembly of HIV type 1. AIDS Res. Hum. Retroviruses. 11:1995;55-64.
9. Cecilia D., Kewal-Ramani V. N., O'Leary J., Volsky B., Nyambi P., Burda S., Xu S., Littman D. R., Zolla-Pazner S. Neutralisation profiles of primary human immunodeficiency virus type 1 isolates in the context of co-receptor usage. J. Virol. 72:1998;6988-6996.
10. Chesebro B., Wehrly K., Metcalf J., Griffin D. E. Use of a new CD4-positive HeLa cell clone for direct quantification of infectious human immunodeficiency virus from blood cells of AIDS patients. J. Infect. Dis. 163:1991;64-70.
11. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodorski J. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
12. Cichutek K., Norley S. Lack of immune suppression in SIV-infected natural hosts. AIDS. 92/93:1993;25-35.
13. Cosset F.-L., Tackeuchi Y., Battini J.-L., Weiss R. A., Collins M. K. I. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995;7430-7436.
14. Deng H. K., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Dimarzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
15. Deng H. K., Unutmaz D., Kewal-Ramani V. N., Littman D. R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388:1997;296-300.
16. Dittmar M. T., Cichutek K., Fultz P., Mullins J., Kuth R. The U3 promotor region of the acutely lethal simian immunodeficiency virus clone smnPBj1.9 confers related biological activity on the apathogenic clone agm3mc. Proc. Natl. Acad. Sci. USA. 92:1995;1362-1366.
17. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. P., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
18. Edinger A. L., Hoffman T. L., Sharron M., Lee B., O'Dowd B., Doms R. W. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology. 249:1998;367-378.
19. Egan M. A., Carruth L. M., Rowell J. F., Yu X., Siliciano R. F. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 70:1996;6547-6556.
20. Eiden M. V., Farrel K. B., Wilson C. A. Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor. J. Virol. 70:1996;1080-1085.
21. Hill C. M., Deng H., Unutmaz D., Kewalramani V. N., Bastiani L., Gorny M. K., Zolla-Pazner S., Littman D. R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:1997;6296-6304.
22. Indraccolo S., Minuzzo S., Feroli F., Mammano F., Calderazzo F., Chieco-Bianchi L., Amadori A. Pseudotyping of moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther. 5:1998;209-217.
23. Kavanaugh M. P., Miller D. G., Zhang W., Law W., Kozak S. L., Kabat D., Miller D. A. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA. 91:1994;7071-7075.
24. Khabbaz R. F., Heneine W., George J. R., Parekh B., Rowe T., Woods T., Switzer W. M., McClure H. M., Murphey-Corb M., Folks T. M. Brief report: infection of a laboratory worker with simian immunodeficiency virus. N. Engl. J. Med. 20:1994;172-177.
25. Kozak S. L., Siess D. C., Kavanaugh M. P., Miller A. D., Kabat D. The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J. Virol. 69:1995;3433-3440.
26. Lee Y. M., Tang X. B., Cimakasky L. M., Hildreth J. E., Yu X. B. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral enevelope glycoproteins in CD4+ T lymphocytes. J. Virol. 71:1997;1443-1452.
27. Lindemann D., Bock M., Schweizer M., Rethwilm A. Efficient pseudotyping of murine leukemia virus with chimeric human foamy virus envelope proteins. J. Virol. 71:1997;4815-4820.
28. Luft J. H. Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9:1964;109-113.
29. Mammano F., Salvatori F., Indraccolo S., De Rossi A., Chieco-Bianchi L., Göttlinger H. G. Truncation of the immunogeficiency virus type 1 envelope allows efficient pseudotyping of murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol. 71:1997;3341-3345.
30. Pomerantz R. J., Trono D. Genetic therapies for HIV infections: promise for the future. AIDS. 9:1995;985-993.
31. Raport C. J., Gosling J., Scheikart V. J., Gray P. W., Charo I. F. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α J. Biol. Chem. 271:1996;17161-17166.
32. Rein A., Mirro J., Haynes J. G., Ernst S. M., Nagashima K. Function of the cytoplasmatic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1994;1773-1781.
33. Sambrook J. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning. 1989;14.5-15.108 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
34. Samson M., Labbe O., Mollereau C., Vassart G. T., Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 35:1996;3362-3367.
35. Sanes J. R., Rubenstein J. L. R., Nicolas J.-F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:1986;3133-3142.
36. Sattentau Q. J., Dalgleish A. G., Weiss R. A., Beverley P. C. L. Epitopes of the CD4 antigen and HIV infection. Science. 234:1986;1120-1123.
37. Schnierle B. S., Stitz J., Bosch V., Nocken F., Merget-Millitzer H., Engelstädter M., Kurth R., Cichutek K. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. USA. 76:1997;8640-8645.
38. Simon M. A., Brodie S. J., Sasseville V. G., Chalifoux L. V., Desrosier R. C., Ringler D. J. Immunopathogenesis of SIVmac. Virus Res. 32:1994;227-251.
39. Soneoka Y., Cannon P. M., Ramsdale E. E., Griffiths J. C., Romano G., Kingsman S. M., Kingsman A. J. A transient three-plasmid expression system for the production of high-titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
40. Stitz J., Müller P., Merget-Millitzer H., Cichutek K. High-titer retroviral pseudotype vectors for the specific targeting of human CD4-positive cells. Biogen. Amin. 14:1998;407-424.
41. Wilk T., Pfeifer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 189:1992;167-177.
42. Yu M., Poeschla E., Wong-Stahl F. Progress towards gene therapy for HIV infection. Gene Ther. 1:1994;13-26.
43. Yu X., Yuan X., Matsuda Z., Lee T. H., Essex M. Role of the C terminus gag protein in human immunodeficiency virus type 1 virion assembly and maturation. J. Virol. 66:1992;4966-4971.
44. Zingler K., Littman D. R. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity. J. Virol. 67:1993;2824-2831.